GO:0071211 protein targeting to vacuole involved in autophagy: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071211 describes the signal-dependent delivery of proteins to the vacuole as part of autophagy, a process essential for cellular homeostasis.
• The pathway relies on conserved machinery including Atg8 family proteins and their LIR/AIM motifs, which mediate cargo selection and membrane targeting.
• In yeast, the cytoplasm-to-vacuole targeting (Cvt) pathway is a prototype for protein targeting to the vacuole during autophagy, requiring Atg9 cycling and Atg11 recruitment.
• Dysregulation of this process is linked to human diseases such as autoimmune glomerular diseases and inflammatory conditions.
• Key genes include ATG9, ATG11, ATG8 family members, and selective autophagy receptors that determine cargo specificity.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of this pathway in disease and drug discovery.
Description
Protein targeting to vacuole involved in autophagy (GO:0071211) is a biological process that directs proteins to the vacuole using intrinsic signals, occurring as part of autophagy, the cellular self-digestion pathway. This term captures a critical step in autophagic flux where cargo proteins are selectively recognized and delivered to the vacuole for degradation or processing. Understanding this process is fundamental for researchers studying cellular quality control, nutrient sensing, and the molecular basis of diseases ranging from neurodegeneration to autoimmune disorders. The pathway is highly conserved from yeast to humans and involves a sophisticated interplay of autophagy-related (ATG) proteins, cargo receptors, and membrane trafficking machinery. In yeast, the cytoplasm-to-vacuole targeting (Cvt) pathway serves as a model for protein targeting to the vacuole during autophagy, requiring the cycling of Atg9 and its recruitment by Atg11. In higher eukaryotes, selective autophagy receptors and Atg8 family proteins with LIR/AIM motifs ensure specificity and efficiency of cargo delivery. This article provides a comprehensive overview of the molecular mechanisms, key genes, disease relevance, and research methodologies for studying GO:0071211, with a focus on how CRISPR-based models can accelerate discovery.
protein targeting to vacuole involved in autophagy At A Glance
| GO ID | GO:0071211 |
|---|---|
| GO term | protein targeting to vacuole involved in autophagy |
| Ontology | biological_process |
| Synonym | protein targeting to autophagosome |
| Major function | Signal-dependent delivery of proteins to the vacuole during autophagy |
| Related pathways | Cytoplasm-to-vacuole targeting (Cvt) pathway, selective autophagy |
| Key machinery | Atg8 family proteins, LIR/AIM motifs, Atg9 cycling, Atg11 |
| Cellular context | Autophagosome formation, vacuolar trafficking |
What Is GO:0071211?
GO:0071211 is defined as the process of directing proteins towards the vacuole using signals contained within the protein, occurring as part of autophagy, the process in which cells digest parts of their own cytoplasm. This term encompasses the signal-dependent recognition, sorting, and transport of specific proteins to the vacuole for degradation or processing during autophagy. It is synonymous with protein targeting to autophagosome in some contexts, reflecting the autophagosome as an intermediate compartment.
Why Is protein targeting to vacuole involved in autophagy Important in Cell Biology?
Protein targeting to vacuole involved in autophagy is essential for cellular homeostasis, allowing cells to degrade damaged proteins and organelles during stress or starvation. Defects in this pathway contribute to the pathogenesis of various human diseases, including autoimmune glomerular diseases, inflammatory disorders, and neurodegenerative conditions. Moreover, the pathway is a promising target for drug discovery, as modulating autophagy-related protein-protein interactions can alter disease progression. Understanding the precise molecular mechanisms of cargo selection and delivery is therefore critical for developing therapeutic interventions.
• Maintains cellular homeostasis by clearing damaged proteins and organelles through autophagy.
• Provides a mechanism for selective degradation of specific proteins via signal-dependent targeting.
• Dysregulation is implicated in autoimmune glomerular diseases and inflammation.
• Serves as a model for studying membrane trafficking and organelle biogenesis.
• Key proteins such as Atg8 and Atg9 are conserved and functionally relevant across species.
• Offers targets for pharmacological modulation in cancer and neurodegeneration.
• Enables nutrient recycling during starvation and stress.
• Involves cargo receptors that determine specificity, impacting cellular proteostasis.
• CRISPR-based editing of pathway genes can reveal causal roles in disease.
• Bioinformatics and library screening can identify novel regulators of this process.
What Happens During protein targeting to vacuole involved in autophagy?
Cargo Recognition and Signal Detection
In simple terms: The cell identifies which proteins need to be sent to the vacuole for degradation.
The process begins with the recognition of specific cargo proteins that contain intrinsic targeting signals. In selective autophagy, cargo receptors such as p62/SQSTM1 and NBR1 bind to ubiquitinated cargo and interact with Atg8 family proteins via LIR/AIM motifs, ensuring specificity. This step is critical for distinguishing proteins destined for vacuolar delivery from other cellular components.
Autophagosome Formation and Cargo Packaging
In simple terms: A membrane sac forms around the cargo to transport it to the vacuole.
Following cargo recognition, a double-membrane structure called the autophagosome forms. Atg9 cycling is essential for supplying membranes to the growing autophagosome, and its recruitment by Atg11 is a key step in the cytoplasm-to-vacuole targeting (Cvt) pathway. The cargo is encapsulated within the autophagosome, which then traffics to the vacuole.
Vacuolar Fusion and Protein Delivery
In simple terms: The transport sac fuses with the vacuole, releasing the proteins inside.
The autophagosome fuses with the vacuole (or lysosome in higher eukaryotes), delivering the cargo proteins into the vacuolar lumen. This fusion step requires SNARE proteins and is regulated by various signaling pathways. Once inside, the proteins are degraded by vacuolar hydrolases, completing the targeting process.
Regulation by Atg8 Family Proteins
In simple terms: Atg8 proteins act like tags that help select and deliver cargo.
Atg8 family proteins (including LC3 and GABARAP in mammals) are conjugated to phosphatidylethanolamine on the autophagosome membrane. They interact with LIR/AIM motifs on cargo receptors and other effectors, facilitating cargo selection and autophagosome maturation. This interaction is a central regulatory node in protein targeting to the vacuole during autophagy.
Key Genes Involved in GO:0071211 protein targeting to vacuole involved in autophagy
The following genes and proteins are central to protein targeting to vacuole involved in autophagy, based on their established roles in cargo recognition, membrane trafficking, and vacuolar delivery.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG9 | Membrane cycling and autophagosome formation | Essential for Cvt pathway and autophagy; target for trafficking studies |
| ATG11 | Recruits Atg9 to the pre-autophagosomal structure | Key in Cvt pathway; mediates cargo selection |
| ATG8 | Ubiquitin-like protein conjugated to autophagosomal membrane | Central to cargo recognition via LIR/AIM motifs |
| LC3B | Mammalian Atg8 homolog | Marker of autophagosomes; interacts with cargo receptors |
| GABARAP | Mammalian Atg8 homolog | Involved in autophagosome maturation and cargo selection |
| SQSTM1/p62 | Selective autophagy receptor | Binds ubiquitinated cargo and Atg8; implicated in disease |
| NBR1 | Selective autophagy receptor | Works with p62 in cargo recognition |
| OPTN | Autophagy receptor | Links cargo to autophagosomes; mutations in neurodegeneration |
| CALCOCO2/NDP52 | Autophagy receptor | Targets bacteria and damaged mitochondria |
| ATG5 | Core autophagy machinery | Required for autophagosome formation |
| ATG7 | E1-like enzyme for Atg8 conjugation | Essential for autophagy and Cvt pathway |
| ATG12 | Ubiquitin-like protein | Conjugates with Atg5 for autophagosome elongation |
| ATG16L1 | Part of Atg12-Atg5-Atg16 complex | Determines site of Atg8 lipidation |
| VPS34 | Phosphatidylinositol 3-kinase | Generates PI3P for autophagosome nucleation |
| ULK1 | Serine/threonine kinase | Initiates autophagy in response to starvation |
| mTOR | Kinase that inhibits autophagy | Regulates pathway in response to nutrients |
| TFEB | Transcription factor | Controls autophagy and lysosomal gene expression |
How Is protein targeting to vacuole involved in autophagy Regulated?
The process of protein targeting to vacuole involved in autophagy is tightly regulated by nutrient-sensing pathways. The mechanistic target of rapamycin (mTOR) kinase inhibits autophagy under nutrient-rich conditions by phosphorylating ULK1 and other components, while starvation or rapamycin treatment activates the pathway. Additionally, the transcription factor TFEB promotes the expression of autophagy and lysosomal genes, enhancing vacuolar targeting capacity. Atg9 cycling and Atg11 recruitment are also regulated by phosphorylation and protein-protein interactions, ensuring proper timing and cargo specificity. Dysregulation of these regulatory mechanisms can lead to disease, highlighting the importance of understanding pathway control.
protein targeting to vacuole involved in autophagy and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TOLLIP | Inflammatory diseases, vacuole trafficking defects | Knockout and point mutation cell models |
| SQSTM1/p62 | Neurodegeneration, Paget disease | Knock-in of disease-associated mutations |
| OPTN | Amyotrophic lateral sclerosis, glaucoma | Knockout and overexpression models |
| ATG16L1 | Crohn's disease | Point mutation knock-in (T300A) |
| mTOR | Cancer, metabolic disorders | Overexpression and knockout for drug screening |
Autoimmune Glomerular Diseases
Defects in autophagy and vacuolar targeting have been implicated in autoimmune glomerular diseases, where impaired clearance of damaged proteins contributes to inflammation and kidney damage. Targeting autophagy components is being explored as a therapeutic strategy.
Inflammatory Disorders
Toll-interacting protein (TOLLIP) impacts inflammation, autophagy, and vacuole trafficking, linking this pathway to human inflammatory diseases. Mutations or dysregulation of TOLLIP can disrupt vacuolar targeting, leading to chronic inflammation.
Cancer
Altered autophagy and vacuolar protein targeting can promote tumorigenesis by allowing cancer cells to survive metabolic stress. Modulating this pathway through protein-protein interaction inhibitors is a promising drug discovery approach.
Neurodegeneration
Impaired clearance of protein aggregates via autophagy contributes to neurodegenerative diseases. Selective autophagy receptors such as OPTN and p62 are linked to amyotrophic lateral sclerosis and other disorders, highlighting the importance of protein targeting to the vacuole.
From protein targeting to vacuole involved in autophagy-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATG9 impair protein targeting to vacuole? | ATG9 knockout cell line |
| How do disease-associated mutations in SQSTM1 affect cargo recognition? | Point mutation knock-in of SQSTM1 |
| Can overexpression of TFEB enhance vacuolar targeting? | TFEB overexpression cell model |
| Where does Atg11 localize during Cvt pathway? | Tagged knock-in of ATG11 with fluorescent protein |
| What is the role of Atg8 lipidation in cargo delivery? | Knockout of ATG7 or ATG5 |
| Can CRISPR library screening identify novel regulators? | Genome-wide CRISPR knockout library |
How to Study the protein targeting to vacuole involved in autophagy Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Co-localization of cargo with vacuole | Tracking protein targeting in live cells |
| Western blot | LC3 lipidation and cargo degradation | Assessing autophagy flux |
| Proteomics | Protein composition of vacuolar fractions | Identifying delivered proteins |
| CRISPR knockout screen | Genes required for pathway | Discovery of novel regulators |
| Pulse-chase | Kinetics of cargo delivery | Cvt pathway analysis |
| Immunoprecipitation | Protein-protein interactions | Mapping LIR/AIM interactions |
| Electron microscopy | Ultrastructure of autophagosomes | Visualizing membrane trafficking |
Fluorescence Microscopy and Live Imaging
Visualizing the co-localization of cargo proteins with vacuolar markers or autophagosomes using fluorescent tags (e.g., GFP-Atg8) allows real-time tracking of protein targeting. This method is essential for confirming delivery to the vacuole.
Proteomics and Immunoblotting
Western blotting for autophagy markers such as LC3-II and cargo proteins can assess pathway activity. Mass spectrometry-based proteomics can identify proteins delivered to the vacuole under different conditions.
Genetic Screens and CRISPR Libraries
Genome-wide CRISPR knockout or activation screens can uncover novel genes required for protein targeting to the vacuole. These unbiased approaches are powerful for identifying regulators and potential drug targets.
Biochemical Assays for Cargo Delivery
Pulse-chase experiments and vacuolar protease protection assays can quantify the efficiency of protein delivery to the vacuole. These methods are particularly useful in yeast models of the Cvt pathway.
How CRISPR Can Be Used to Study GO:0071211 protein targeting to vacuole involved in autophagy
Knockout
CRISPR knockout of genes such as ATG9, ATG11, or ATG8 family members can abolish protein targeting to the vacuole, providing definitive evidence of their essential roles. Knockout cell lines are valuable for studying pathway necessity and for drug screening.
Point Mutation
Introducing disease-associated point mutations (e.g., in SQSTM1 or OPTN) via CRISPR base editing or HDR allows researchers to dissect the functional impact of specific variants on cargo recognition and vacuolar delivery.
Knock-in
Knock-in of fluorescent or epitope tags (e.g., GFP-ATG8) enables real-time visualization and biochemical isolation of pathway components. This approach is ideal for tracking protein targeting dynamics in live cells.
Overexpression
CRISPR activation or cDNA overexpression of genes like TFEB or ATG9 can enhance vacuolar targeting, allowing gain-of-function studies and identification of rate-limiting steps. Overexpression models are useful for testing therapeutic hypotheses.
How EDITGENE Supports protein targeting to vacuole involved in autophagy Research
Researchers studying protein targeting to vacuole involved in autophagy-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activity. Precise genetic models are essential to establish causality, dissect molecular mechanisms, and validate therapeutic targets. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for protein targeting to vacuole involved in autophagy research.
Frequently Asked Questions About protein targeting to vacuole involved in autophagy
What is GO:0071211?
GO:0071211 is the Gene Ontology term for protein targeting to vacuole involved in autophagy, describing the signal-dependent delivery of proteins to the vacuole during autophagy.
What genes are involved in protein targeting to vacuole involved in autophagy?
Key genes include ATG9, ATG11, ATG8 family members (LC3, GABARAP), selective autophagy receptors (p62, NBR1, OPTN), and core autophagy machinery such as ATG5, ATG7, and ATG16L1.
How does protein targeting to vacuole occur?
It occurs through cargo recognition by receptors, autophagosome formation, and fusion with the vacuole, delivering proteins for degradation.
What is the role of Atg8 in this process?
Atg8 family proteins are conjugated to the autophagosome membrane and interact with LIR/AIM motifs on cargo receptors to ensure selective targeting.
What diseases are linked to defects in this pathway?
Defects are linked to autoimmune glomerular diseases, inflammatory disorders, cancer, and neurodegeneration.
How can I study protein targeting to vacuole in the lab?
Common methods include fluorescence microscopy, Western blotting, proteomics, and CRISPR screens.
What is the Cvt pathway?
The cytoplasm-to-vacuole targeting (Cvt) pathway is a yeast-specific biosynthetic route that delivers hydrolases to the vacuole and serves as a model for autophagy-related targeting.
Can CRISPR be used to study this pathway?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this pathway.
What is the difference between autophagy and the Cvt pathway?
Autophagy is a bulk degradation process, while the Cvt pathway is a selective biosynthetic pathway for specific vacuolar enzymes; both share core machinery.
How does mTOR regulate this process?
mTOR inhibits autophagy under nutrient-rich conditions; inhibition of mTOR by starvation or rapamycin activates protein targeting to the vacuole.
Conclusion
Protein targeting to vacuole involved in autophagy (GO:0071211) is a fundamental cellular process that ensures the selective delivery of proteins to the vacuole for degradation or processing. Its tight regulation and conservation across species underscore its importance in health and disease. Advances in CRISPR-based models and screening technologies are accelerating our understanding of this pathway and its therapeutic potential. EDITGENE offers comprehensive services to support researchers in dissecting the molecular mechanisms and disease relevance of this critical process.
References
- 1. Nakatogawa H. 2020. Mechanisms governing autophagosome biogenesis.. Nat Rev Mol Cell Biol 21(8):439-458 PMID: 32372019
- 2. Xiang H et al.. 2023. Drug discovery by targeting the protein-protein interactions involved in autophagy.. Acta Pharm Sin B 13(11):4373-4390 PMID: 37969735
- 3. Rogov VV et al.. 2023. Atg8 family proteins, LIR/AIM motifs and other interaction modes.. Autophagy Rep 2(1) PMID: 38214012
- 4. Li X et al.. 2021. Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease.. J Mol Med (Berl) 99(1):21-31 PMID: 33128579
- 5. Ponticelli C et al.. 2025. Targeting autophagy in autoimmune glomerular diseases.. J Nephrol 38(7):1761-1772 PMID: 40106213
- 6. Kirkin V et al.. 2019. A Diversity of Selective Autophagy Receptors Determines the Specificity of the Autophagy Pathway.. Mol Cell 76(2):268-285 PMID: 31585693
- 7. Munakata N et al.. 2010. "Autophagy suite": Atg9 cycling in the cytoplasm to vacuole targeting pathway.. Autophagy 6(6):679-85 PMID: 20543572
- 8. Coudevylle N et al.. 2022. Mechanism of Atg9 recruitment by Atg11 in the cytoplasm-to-vacuole targeting pathway.. J Biol Chem 298(2):101573 PMID: 35007534
